Core Viewpoint - The company, Aoyang Health (002172.SZ), announced that its controlling shareholder, Aoyang Group, is planning to transfer shares, which may lead to a change in the controlling shareholder and actual controller of the company [1] Group 1 - Aoyang Group notified the company on September 8, 2025, regarding the share transfer plan, with specific ratios and transaction methods to be determined through further negotiations [1] - The company's stock was suspended from trading on September 9, 2025, due to this announcement [1] - As of the announcement date, the parties involved are actively negotiating the overall transaction plan, and no formal agreement has been signed yet [1] Group 2 - The company anticipates that it will not be able to resume trading on September 11, 2025, and the stock will continue to be suspended [1] - The expected duration of the trading suspension is no more than three trading days [1]
澳洋健康(002172.SZ):筹划公司控制权变更事项 股票继续停牌